Bruce Donald's company featured at Duke Venture Day

Gavilan Biodesign Company Logo

Bruce Donald's company featured at Duke Venture Day

Bruce Donald’s company, Gavilán Biodesign, was featured as one of eight Duke start-up investments at the first Duke Venture Day earlier this month. This event showcased therapeutic innovations currently coming out of Duke. Gavilan Biodesign was recently selected as one of 11 early-stage biotech companies at the Silicon Valley biotech accelerator, IndieBio. Their technology combines state of the art physics-based modeling with a unique high accuracy AI platform to computationally screen trillions of molecules in order to find therapeutics that can overcome resistance. 

Story adopted from an article originally posted on the Office of Licensing and Ventures on May 9, 2019.

Related News

Svati Shah headshot

Svati Shah Named Director of Duke Precision Genomics Collaboratory

Svati Shah, M.D., MHS, has been appointed director of the Duke Precision Genomics Collaboratory and associate dean of genomics.


GCB Receives Grant To Create New International Training Program

The Center for Genomic and Computational Biology (GCB) received a grant from the National Science Foundation (NSF) to create an International Research Experiences for Students (IRES) program called “Dissecting the Regulatory Genome Duke-Berlin Training Program.”
Stack of Books

Research Roundup: May 2019

Here are summaries of a selection of the papers published by GCB faculty in May 2019: